Dr. Ahmed Serag is Professor, Founder and Director of the AI Innovation Lab. With over 17 years of experience, he has specialized in the intersection of Artificial Intelligence (AI) and its real-world applications, making significant contributions to both academia and industry.

Before joining WMC-Q, Dr. Serag held several leadership positions at healthcare and pharmaceutical organizations in the USA, Europe, and the UK. He was the VP Global Director of Data Science and AI Innovation at Novartis, where he spearheaded multiple initiatives and partnerships, fueling the development and discovery of innovative medicines. Prior to that, he served as the Head of AI Research and Innovation at Philips Healthcare, overseeing the creation of the first commercial Deep Learning Algorithms for the identification and quantification of tumors in molecular pathology, and the Brain Metabolism Analysis tool which Philips considers as a breakthrough in medical diagnostics.

Dr. Serag's academic journey has been marked by numerous accolades and achievements, with a focus on leveraging AI techniques to advance medical research. A central aspect of his work has been the development of dynamic 4D models of the human brain, instrumental in understanding brain development and maturation trajectories throughout life. His insights in this area have paved the way for more accurate and efficient diagnostic approaches, benefiting researchers, patients and healthcare professionals alike.

Dr. Serag's impact extends beyond his professional roles, as evidenced by his extensive publication record of about 100 original research articles. Furthermore, he is a frequent keynote speaker, and advising various organisations on AI strategies.

Dr. Serag earned a Ph.D. in Computer Science from Imperial College London in the UK.